GVK BIOSCIENCES PRIVATE LIMITED

Hyderabad-based GVK Biosciences (GVK BIO) generated a revenue of Rs 950 crore during the FY19-20, exhibiting a growth of 20 per cent in comparison to the revenue figure of Rs 793 generated in the previous year. During the FY1920, GVK BIO and BE Pharmaceuticals Inc (BE Inc), a subsidiary of Biological E. Limited, announced a strategic collaboration in drug product development. As part of the partnership, GVK BIO is developing a certain set of injectable products for BE Inc. The FY19-20 also saw Aragen Bioscience, Inc, a subsidiary unit of GVK BIO, entering into collaboration with Pune based Serum Institute of India Pvt. Ltd. for the development of multiple stable cell lines to support Serum’s HIV programme.